GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.
The current price of WGSWW is $0.01 USD — it has decreased by -1.25% in the past 24 hours. Watch GeneDx stock price performance more closely on the chart.
What is GeneDx stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange GeneDx stocks are traded under the ticker WGSWW.
Is GeneDx stock price growing?▼
WGSWW stock has risen by +27.42% compared to the previous week, the month change is a -42.34% fall, over the last year GeneDx has showed a -95.34% decrease.
What is GeneDx market cap?▼
Today GeneDx has the market capitalization of 231,383.1
When is the next GeneDx earnings date?▼
GeneDx is going to release the next earnings report on May 13, 2026.
What were GeneDx earnings last quarter?▼
WGSWW earnings for the last quarter are 0.14 USD per share, whereas the estimation was 0.1 USD resulting in a +36.8% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is GeneDx revenue for the last year?▼
GeneDx revenue for the last year amounts to 855.08M USD.
What is GeneDx net income for the last year?▼
WGSWW net income for the last year is -42.04M USD.
How many employees does GeneDx have?▼
As of April 02, 2026, the company has 1,000 employees.